Loading clinical trials...
Loading clinical trials...
Open-label, Multicenter, Randomized, Parallel Study to Investigate pk, pd, Efficacy and Safety of Tocilizumab (TCZ, RO4877533) Following Subcutaneous Administration of TCZ 162 mg Weekly or Every Other Week in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Conditions
Interventions
folic acid
methotrexate
+2 more
Locations
7
Canada
St. John's, Newfoundland and Labrador, Canada
Kitchener, Ontario, Canada
Trois-Rivières, Quebec, Canada
Christchurch, New Zealand
A Coruña, La Coruña, Spain
Santiago de Compostela, La Coruña, Spain
Start Date
August 1, 2009
Completion Date
July 1, 2011
Last Updated
November 2, 2016
NCT06647069
NCT07484243
NCT06841562
NCT07268326
NCT07233655
NCT07029555
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions